Endogenic PharmacologyThe Canonical Reference
The Taxonomy · Clinical Paradigm

Bioregulatory Medicine

The clinical practice of endogenic pharmacology. The translation of the discipline into therapeutic protocols.

Definition

The clinical practice of the discipline.

Bioregulatory medicine is the clinical practice of endogenic pharmacology. Where endogenic pharmacology defines the science, bioregulatory medicine defines the practice — the translation of scientific principles into therapeutic protocols, dosing schedules, indication selection, patient stratification, and outcome measurement.

It is distinct from integrative medicine, functional medicine, or naturopathic medicine. Bioregulatory medicine is rigorously pharmacological in its mechanisms, sources its therapeutic compounds from peer-reviewed and patent-protected research, and operates through the same regulatory pathways and clinical-evidence standards as conventional pharmaceutical practice.

Indication Areas

Five primary therapeutic domains.

Neurological

Cognitive maintenance, age-associated neurological decline, peripheral nerve regeneration, neuroinflammation, and circadian regulation.

Immune

T-cell competence restoration, immunosenescence, post-acute immune recovery, and the regulation of the thymus-adrenal-gonadal axis.

Vascular

Endothelial function, vascular age reversal, post-event recovery, and microvascular regulation in metabolic and inflammatory states.

Longevity

Telomerase regulation, senescent-cell modulation, hormonal-axis maintenance, and the integrated multi-system protocols characteristic of clinical longevity practice.

Metabolic

Pancreatic regulation, glucose homeostasis, hepatic function, and the metabolic-syndrome profile addressable through endogenous regulatory restoration.

Distribution

Two clinical tiers.

Bioregulatory therapeutics are distributed at two tiers, each governed by distinct regulatory pathways and clinical-evidence requirements. Together they make the discipline accessible at appropriate levels of clinical supervision.

Tier I · Opticeuticals

Consumer access.

Bioregulatory compositions formulated for over-the-counter consumer use. Topical, transdermal, intranasal, sublingual, and oral delivery formats. Designed for daily maintenance and self-directed use within published safety windows.

The opticeutical class
  1. Access
    Over-the-counter; no prescription required.
  2. Supervision
    Consumer-directed within labeled use; no clinical gating.
  3. Delivery formats
    Topical, transdermal, intranasal, sublingual, oral.
  4. Regulatory pathway
    Cosmetic and supplement pathways with bioregulator-class evidence.
  5. Manufacturing
    GMP-aligned consumer-product standards.
  6. Use profile
    Daily maintenance, age-associated decline, restorative regimens.
Tier II · Endoceuticals

Prescription practice.

Bioregulatory compositions dispensed under clinical supervision for defined therapeutic indications. Subject to the same regulatory pathways and clinical-evidence standards as conventional pharmaceutical practice.

The endoceutical class
  1. Access
    Prescription-only; dispensed under licensed clinical authority.
  2. Supervision
    Indication selection, dosing, and monitoring by a treating clinician.
  3. Delivery formats
    Full pharmaceutical breadth including parenteral and depot formats.
  4. Regulatory pathway
    Pharmaceutical pathways with INDs, clinical trials, and label indications.
  5. Manufacturing
    Pharmaceutical-grade GMP with full chain-of-custody documentation.
  6. Use profile
    Diagnosed indications across neuro, immune, vascular, metabolic, longevity domains.